I-2021 Radiopharmaceutical Therapy in Benign and Malignant Diseases: I-Radiotheragnostic Practicum | Izifundo zevidiyo yezokwelapha.

2021 Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum

Intengo ejwayelekile
$50.00
Intengo yokuthengiswa
$50.00
Intengo ejwayelekile
Kuthengisiwe
Intengo yokukodwa
ngayinye 

Ukwelashwa kwe-2021 Radiopharmaceutical ku-Benign and Malignant Diseases: Radiotheragnostic Practicum

UZOTHOLA ISIQINISEKISO NGOKUXELWA KWESIKHATHI SOKUPHILA KWESIKHATHI SOKUPHILA NGOKUSHESHA NGEMVA KOKUKHOKHWA

Lo msebenzi oqhubekayo wemfundo ubuyekeza imikhuba emihle emkhakheni okhulayo we-radiotheragnostics (aka theranostics noma theragnostics) yezifo ezinobungozi neziyingozi, kuqala ngezisekelo futhi ezinwebekayo ukufaka izicelo eziphambili zomtholampilo. Kufakiwe ukubuyekezwa kwezindlela zokwelapha ezisungulwe ngokomlando ezenziwe zaba zesimanje ngokuhle kanye nezindlela zobuchwepheshe ezisanda kwethulwa ezifakiwe. Isazi sobuchwepheshe sixoxa ngokwenziwa kahle kwemikhuba ye-radiotheragnostic yokusetshenziswa okungcono kwama-radiopharmaceuticals ezinhlelweni zokulethwa kwezempilo zesimanje, zombili izilungiselelo zezemfundo nezizimele.

Izilaleli ezibhekele 

Lo mhlangano wenzelwe odokotela bemithi yenuzi, abasebenza ngemisebe yenuzi, odokotela bama-oncologists, ososayensi bezempilo kanye nabasebenza ngemisebe yenuzi.

Izinjongo zezemfundo
Ekuqedeni lo msebenzi we-CME, ababhalisile kufanele bakwazi:

- Umehluko phakathi kwendlela ye-radiotheragnostic neminye imiqondo ehlukahlukene eqondisa ukulethwa kokwelashwa kwemisebe ezicutshini ezihlosiwe ngenhloso yokwenza ngcono imiphumela yezempilo.
- Umkhuba omuhle kakhulu wokwelapha osondela ku-hyperthyroidism nezinye izifo ezinobungozi ze-thyroid, ngokususelwa ebufakazini kanye / noma ekwahlulelweni kwezempilo okuzwakalayo.
- Umkhuba omuhle kakhulu wokwelashwa usondela ekuhlukaniseni i-thyroid carcinoma, ngokuya ngobufakazi kanye / noma nesahlulelo sezempilo esizwakalayo.
- Ukusetshenziswa okuhle kwe-Y-90 Ibritumomab Tiuxetan ekwelashweni kwe-lymphoma.
- Ukusetshenziswa okuhle kwe-I-131 Iobenguane ekucabangeni ngemifanekiso kanye nokwelashwa kwePheochromocytoma neParaganglioma.
- Ukusetshenziswa okuhle kwe-Y-90 Resin kanye ne-Glass Microspheres ekwelashweni kwe-radioembolization yomdlavuza wesibindi.
- Ukusetshenziswa okuhle kwe-Ga-68 Dotatate Imaging kanye ne-Lu-177 Dotatate therapy yamathumba we-neuroendocrine.
- Indlela enhle yokuthola isithombe sokuxilonga somdlavuza we-prostate ophindaphindiwe kanye ne-metastatic.
- Indlela engcono kakhulu yokwelashwa kwezifo zamathambo ezisetshenziswa ngamathambo kusetshenziswa ama-radiopharmaceuticals ahlukahlukene afuna amathambo.
- Izibonelo ezingokoqobo zokuhlolwa komdlavuza ongabhalisiwe wezivivinyo ezenzelwe i-radiotheragnostics.
- Izindlela ezihamba phambili zokwakha umkhuba we-radiotheragnostic ezikhungweni zemfundo.
- Izindlela ezihamba phambili zokwakha umkhuba we-radiotheragnostic kuzilungiselelo zomkhuba wangasese.

    Izihloko Nezipikha:

     

    Umlando Nokwenza kweRadioiodine Therapy kuHyperthyroidism
    UMark Tulchinsky, MD, FACNM, FSNMMI, i-CCD

    Sibutsetelo Sokwelapha Okuhlosiwe - Izifundo Ozifundile
    UTerence Z. Wong, MD, Ph.D.

    I-Radioiodine Therapy: Izimo Ezingajwayelekile Zebhentshi
    UMark Tulchinsky, MD, FACNM, FSNMMI, i-CCD

    I-131 Iobenguane Imaging & Therapy yePheochromocytoma / Paraganglioma
    U-Erik S. Mittra MD, Ph.D.

    I-Radioiodine ku-Cancer Cancer - Okuyisisekelo
    UMark Tulchinsky, MD, FACNM, FSNMMI, i-CCD

    I-Radioiodine ku-Cancer Cancer - Kuthuthukile
    UMark Tulchinsky, MD, FACNM, FSNMMI, i-CCD

    Ukwelashwa kweRadioembolization nge-Y-90 Resin ne-Glass Microspheres
    UTerence Z. Wong, MD, Ph.D.

    Ukufanekisa kwe-Ga-68 / Lu-177 Dotatate / Therapy of Neuroendocrine Tumors
    U-Erik S. Mittra MD, Ph.D.

    Ukufanekisa Ukuxilonga Komdlavuza We-Prostate Wokuphindaphinda
    USamuel Mehr, MD

    Ukwelashwa Kwezifo ZeMisipha Yamathambo Nabenzeli Bokufuna Amathambo
    UTerence Z. Wong, MD, Ph.D.

    AmaRadiotheragnostics kuCancer yeProstate
    UTerence Z. Wong, MD, Ph.D.

    Izilingo ezibalulekile e-USA ze-Radiotheragnostics Ephezulu Nokuzayo
    U-Erik S. Mittra MD, Ph.D.

    Amathuba okubhekiswa kwe-Somatostatin Receptor ku-Avid Cancers
    USamuel Mehr, MD

    Ukwakha Uhlelo Lokwelashwa Kwemithi Yenyukliya Ekuzifundiseni
    U-Erik S. Mittra MD, Ph.D.

    Ukwakha Uhlelo Lokwelashwa Kwemithi Yenyukliya Ekuzilungiseleleni Okuzimele
    USamuel Mehr, MD

    Sale

    Ayitholakali

    Kuthengisiwe